IDH1 and glioblastoma: For example, work from Calvert et al. using in silico and wet-bench analyses shows that non-mutated isocitrate dehydrogenase 1 (IDH1) is commonly overexpressed in the primary GBM and genetic and pharmacological inactivation leads to attenuation of GBM tumor growth [14].